Skip to main content
Log in

Determinants of surgical repair of patent ductus arteriosus in low-birth-weight infants

  • Original Article
  • Published:
Journal of Medical Ultrasonics Aims and scope Submit manuscript

Abstract

Purpose

To identify risk factors related to the failure of indomethacin therapy and the need for surgical repair in patent ductus arteriosus (PDA) in extremely low-birth-weight (<1000 g) infants (ELBWI).

Methods

Study subjects were 36 ELBWI with PDA born at a single tertiary perinatal center. They were classified into those who required surgery due to failure of indomethacin treatment (surgical group, n = 21) and those with effective indomethacin treatment (non-surgical group, n = 15). The odds ratios (ORs) and 95% confidence intervals (95% CIs) for the relationship between selected risk factors and surgical treatment of PDA were calculated.

Results

Gestational age of <28 weeks and diameter of PDA of 2 mm or more were independent and significant determinants of the need for surgical repair of PDA (adjusted ORs [95% CIs] = 9.91 [1.16–84.48] and 24.80 [2.72–225.74], respectively). The need for surgical repair of PDA did not correlate with sex, birth weight, 1-min Apgar score, left atrium diameter/aortic diameter (LA/Ao), left ventricular internal dimension at end-diastole, prophylaxes with indomethacin, and total dosage of indomethacin.

Conclusions

Gestational age at birth of <28 weeks and diameter of PDA of 2 mm or more are determinants of failure of indomethacin treatment for PDA and the need for surgical repair.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Hammerman C, Kaplan M. Comparative tolerability of pharmacological treatments for patent ductus arteriosus. Drug Saf. 2001;24:537–51.

    Article  PubMed  CAS  Google Scholar 

  2. Kitterman JA, Edmunds LH Jr, Gregory GA, et al. Patent ductus arteriosus in premature infants. Incidence, relation to pulmonary disease and management. N Engl J Med. 1972;287:473–7.

    Article  PubMed  CAS  Google Scholar 

  3. Ichihashi K, Shiraishi H, Endou H, et al. Cerebral and abdominal arterial hemodynamics in preterm infants with patent ductus arteriosus. Acta Paediatr Jpn. 1990;32:349–56.

    PubMed  CAS  Google Scholar 

  4. Heymann MA, Rudolph AM, Silverman NH. Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. N Engl J Med. 1976;295:530–3.

    Article  PubMed  CAS  Google Scholar 

  5. Amin SB, Handley C, Carter-Pokras O. Indomethacin use for the management of patent ductus arteriosis in preterms: a web-based survey of practice attitudes among neonatal fellowship program directors in the United States. Pediatr Cardiol. 2007;28:193–200.

    Article  PubMed  CAS  Google Scholar 

  6. Little DC, Pratt TC, Blalock SE, et al. Patent ductus arteriosus in micropreemies and full-term infants: the relative merits of surgical ligation versus indomethacin treatment. J Pediatr Surg. 2003;38:492–6.

    Article  PubMed  Google Scholar 

  7. Shaffer CL, Gal P, Ransom JL, et al. Effect of age and birth weight on indomethacin pharmacodynamics in neonates treated for patent ductus arteriosus. Crit Care Med. 2002;30:343–8.

    Article  PubMed  CAS  Google Scholar 

  8. Alexander F, Chiu L, Kroh M, et al. Analysis of outcome in 298 extremely low-birth-weight infants with patent ductus arteriosus. J Pediatr Surg. 2009;44:112–7. disscusion 117.

    Article  PubMed  Google Scholar 

  9. Narayanan M, Cooper B, Weiss H, Clyman RI. Prophylactic indomethacin: factors determining permanent ductus arteriosus closure. J Pediatr. 2000;136:330–7.

    Article  PubMed  CAS  Google Scholar 

  10. Schwartz MZ, Palder SB, Tyson KR, et al. Complications of prematurity that may require surgical intervention. Arch Surg. 1988;123:1135–8.

    PubMed  CAS  Google Scholar 

  11. Hermes-DeSantis ER, Clyman RI. Patent ductus arteriosus: pathophysiology and management. J Perinatol. 2006;26:S14–8. discussion S22–S23.

    Article  PubMed  Google Scholar 

  12. Boo NY, Mohd-Amin I, Bilkis AA, et al. Predictors of failed closure of patent ductus arteriosus with indomethacin. Singapore Med J. 2006;47:763–8.

    PubMed  CAS  Google Scholar 

  13. Ekici F, Atasay B, Gunlemez A, et al. Management of patent ductus arteriosus in preterm infants. Anadolu Kardiyol Derg. 2006;6:28–33.

    PubMed  Google Scholar 

  14. Lin CT, Liu WH, Cheng BC, et al. Surgical closure of patent ductus arteriosus in preterm infants at neonatal intensive care unit. Acta Paediatr Taiwan. 2003;44:287–91.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yukako Yoshikane.

About this article

Cite this article

Yoshikane, Y., Mori, T., Yoshizato, T. et al. Determinants of surgical repair of patent ductus arteriosus in low-birth-weight infants. J Med Ultrasonics 38, 151–155 (2011). https://doi.org/10.1007/s10396-011-0309-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10396-011-0309-8

Keywords

Navigation